Prospective, Randomized, Controlled, Blinded Pivotal Study In Subjects Undergoing A Transforaminal Lumbar Interbody Fusion (TLIF) At One Or Two Levels Using Infuse™ Bone Graft With an Intervertebral Body Fusion Device and Posterior Supplemental Fixation For The Treatment Of Symptomatic Degenerative Disease Of The Lumbosacral Spine
-
Enrollment
This study is currently enrolling. -
Research Area
Neuroscience Research -
Location
-
Principal Investigator
-
Sponsor
Medtronic Sofamor Danek USA, Inc.
The purpose of this study is to evaluate the Infuse™ Bone Graft in combination with other spinal devices and autograft bone (your own bone) to see if it is safe and effective when used in a TLIF surgery. Two different amounts of the Infuse™ Bone Graft material will be tested.
Enrollment Form
This study is currently enrolling.